257 related articles for article (PubMed ID: 8679271)
1. Radiolabeled monoclonal antibodies in diagnosis and therapy of cancer. Summary and perspectives.
Britton KE
Acta Oncol; 1996; 35(3):385-90. PubMed ID: 8679271
[TBL] [Abstract][Full Text] [Related]
2. Animal models for radiolabeled monoclonal antibodies in cancer research.
Aas M; Fjeld JG
Acta Oncol; 1993; 32(7-8):819-24. PubMed ID: 8305231
[TBL] [Abstract][Full Text] [Related]
3. 3rd Scandinavian Symposium on Radiolabeled Monoclonal Antibodies for Cancer Diagnosis and Therapy. Proceedings. Helsinki, Finland, October 30-31, 1992.
Acta Oncol; 1993; 32(7-8):707-891. PubMed ID: 7905745
[No Abstract] [Full Text] [Related]
4. 4th Scandinavian Symposium on Radiolabeled Monoclonal Antibodies in Diagnosis and Therapy of Cancer. Lillehammer, Norway, January 15-17, 1995.
Acta Oncol; 1996; 35(3):257-390. PubMed ID: 8679253
[No Abstract] [Full Text] [Related]
5. Phase I/II clinical radioimmunotherapy with an iodine-131-labeled anti-carcinoembryonic antigen murine monoclonal antibody IgG.
Behr TM; Sharkey RM; Juweid ME; Dunn RM; Vagg RC; Ying Z; Zhang CH; Swayne LC; Vardi Y; Siegel JA; Goldenberg DM
J Nucl Med; 1997 Jun; 38(6):858-70. PubMed ID: 9189130
[TBL] [Abstract][Full Text] [Related]
6. Introduction to this special issue on tumor targeting.
Goldenberg DM
Tumour Biol; 2012 Jun; 33(3):571-2. PubMed ID: 22492239
[No Abstract] [Full Text] [Related]
7. [Monoclonal antibodies for diagnosis and therapy in oncological patients].
Boven E; Haisma HJ; Pinedo HM
Ned Tijdschr Geneeskd; 1995 Dec; 139(49):2552-8. PubMed ID: 8657317
[No Abstract] [Full Text] [Related]
8. Optimizing radioimmunotherapy by matching dose distribution with tumor structure using 3D reconstructions of serial images.
Flynn AA; Pedley RB; Green AJ; Boxer GM; Boden R; Begent RH
Cancer Biother Radiopharm; 2001 Oct; 16(5):391-400. PubMed ID: 11776756
[TBL] [Abstract][Full Text] [Related]
9. The 10th International Conference on Monoclonal Antibody Immunoconjugates for Cancer: Radiodosimetry and Radiopharmaceuticals for Therapy.
Breitz H; Mills G; Siegel J; Stabin M; Wessels BW
Cancer Biother Radiopharm; 1996 Feb; 11(1):25-42. PubMed ID: 10851518
[No Abstract] [Full Text] [Related]
10. [Radioimmunotargeting: diagnosis and therapeutic use].
Vuillez JP
Bull Cancer; 2000 Nov; 87(11):813-27. PubMed ID: 11125290
[TBL] [Abstract][Full Text] [Related]
11. Targeting cancer with radiolabeled antibodies.
Goldenberg DM; Larson SM; Reisfeld RA; Schlom J
Immunol Today; 1995 Jun; 16(6):261-4. PubMed ID: 7662094
[No Abstract] [Full Text] [Related]
12. Recent achievements in the development of radiolabeled monoclonal antibodies for diagnosis, therapy and biologic characterization of human tumors.
Larson SM; Macapinlac HA; Scott AM; Divgi CR
Acta Oncol; 1993; 32(7-8):709-15. PubMed ID: 8305216
[TBL] [Abstract][Full Text] [Related]
13. Future role of radiolabeled monoclonal antibodies in oncological diagnosis and therapy.
Goldenberg DM
Semin Nucl Med; 1989 Oct; 19(4):332-9. PubMed ID: 2678484
[TBL] [Abstract][Full Text] [Related]
14. [Immunoscintigraphy and radioimmunotherapy of cancer using monoclonal antibodies].
Oriuchi N
Gan To Kagaku Ryoho; 1999 May; 26(6):762-7. PubMed ID: 10410144
[TBL] [Abstract][Full Text] [Related]
15. Pretargeted Nuclear Imaging and Radioimmunotherapy Based on the Inverse Electron-Demand Diels-Alder Reaction and Key Factors in the Pretargeted Synthetic Design.
Qiu L; Mao W; Yin H; Tan H; Cheng D; Shi H
Contrast Media Mol Imaging; 2019; 2019():9182476. PubMed ID: 31531006
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunotherapy dosimetry--a review.
Strand SE; Jönsson BA; Ljungberg M; Tennvall J
Acta Oncol; 1993; 32(7-8):807-17. PubMed ID: 8305230
[TBL] [Abstract][Full Text] [Related]
17. The direct route may not be the best way to home.
Sharkey RM
J Nucl Med; 2005 Mar; 46(3):391-4. PubMed ID: 15750148
[No Abstract] [Full Text] [Related]
18. Monoclonal antibodies in solid tumours: approaches to therapy with emphasis on gynaecological cancer.
Fleckenstein G; Osmers R; Puchta J
Med Oncol; 1998 Dec; 15(4):212-21. PubMed ID: 9951683
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease: a target for radioimmunotherapy with 131I-labeled monoclonal antibodies? Some dosimetric considerations.
Sautter-Bihl ML; Herbold G; Bihl H
Recent Results Cancer Res; 1996; 141():67-75. PubMed ID: 8722420
[No Abstract] [Full Text] [Related]
20. Imaging and therapy with monoclonal antibodies in non-hematopoietic tumors.
Mach JP; Pèlegrin A; Buchegger F
Curr Opin Immunol; 1991 Oct; 3(5):685-93. PubMed ID: 1755986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
